Last $6.00 USD
Change Today -0.463 / -7.17%
Volume 83.9K
As of 5:10 PM 11/28/14 All times are local (Market data is delayed by at least 15 minutes).

oramed pharmaceuticals inc (ORMP) Snapshot

Open
$6.59
Previous Close
$6.46
Day High
$6.59
Day Low
$5.81
52 Week High
01/13/14 - $31.73
52 Week Low
11/28/14 - $5.81
Market Cap
60.6M
Average Volume 10 Days
45.8K
EPS TTM
$-0.62
Shares Outstanding
10.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ORAMED PHARMACEUTICALS INC (ORMP)

oramed pharmaceuticals inc (ORMP) Related Bloomberg News

View More Bloomberg News

oramed pharmaceuticals inc (ORMP) Related Businessweek News

No Related Businessweek News Found

oramed pharmaceuticals inc (ORMP) Details

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. Its product portfolio includes ORMD-0801, an oral insulin capsule that completed Phase IIa clinical trials for the treatment of diabetes; and ORMD-0901, an analog for GLP-1 gastrointestinal hormone, which is in pre-clinical trials for the treatment of type 2 diabetes. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in Jerusalem, Israel.

oramed pharmaceuticals inc (ORMP) Top Compensated Officers

Chief Executive Officer, President and Execut...
Total Annual Compensation: $381.3K
Chief Financial Officer, Treasurer and Secret...
Total Annual Compensation: $193.8K
Chief Operating Officer and Vice President of...
Total Annual Compensation: $199.2K
Chief Medical & Technology Officer and Direct...
Total Annual Compensation: $271.3K
Compensation as of Fiscal Year 2014.

oramed pharmaceuticals inc (ORMP) Key Developments

Oramed Pharmaceuticals Inc. Presents at FireRock Conference, Oct-28-2014 09:15 AM

Oramed Pharmaceuticals Inc. Presents at FireRock Conference, Oct-28-2014 09:15 AM. Venue: Spring Mills Landmark Building, 104 West 40(th) Street, New York, New York, United States.

Oramed Pharmaceuticals Inc. Presents at FireRock annual Micro-Cap Conference 2014, Oct-28-2014 09:15 AM

Oramed Pharmaceuticals Inc. Presents at FireRock annual Micro-Cap Conference 2014, Oct-28-2014 09:15 AM. Venue: The Spring Mills Landmark Building, 104 W. 40th St, New York, United States. Speakers: Nadav Kidron, Chief Executive Officer, President and Executive Director.

Oramed Pharmaceuticals Inc. - Special Call

To present detailed data from top-line clinical results from its Phase IIa clinical trial of ORMD-0801

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ORMP:US $6.00 USD -0.463

ORMP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ORMP.
View Industry Companies
 

Industry Analysis

ORMP

Industry Average

Valuation ORMP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 3.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORAMED PHARMACEUTICALS INC, please visit www.oramed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.